Avanos Medical FY2026 EPS Forecast Reduced by Zacks Research

Avanos Medical, Inc. (NYSE:AVNS) – Research analysts at Zacks Research cut their FY2026 EPS estimates for Avanos Medical in a note issued to investors on Tuesday, December 3rd. Zacks Research analyst R. Department now anticipates that the company will earn $2.00 per share for the year, down from their prior forecast of $2.01. The consensus estimate for Avanos Medical’s current full-year earnings is $1.32 per share.

Separately, StockNews.com downgraded Avanos Medical from a “strong-buy” rating to a “buy” rating in a research note on Sunday, November 3rd.

Avanos Medical Trading Down 1.1 %

NYSE AVNS opened at $18.89 on Thursday. The stock has a market cap of $868.18 million, a P/E ratio of 55.56 and a beta of 0.95. The stock’s fifty day moving average price is $20.87 and its 200-day moving average price is $21.49. Avanos Medical has a 12 month low of $17.39 and a 12 month high of $25.36. The company has a current ratio of 2.22, a quick ratio of 1.46 and a debt-to-equity ratio of 0.12.

Institutional Investors Weigh In On Avanos Medical

Institutional investors and hedge funds have recently added to or reduced their stakes in the stock. Quarry LP purchased a new stake in Avanos Medical during the third quarter valued at approximately $42,000. KBC Group NV raised its stake in shares of Avanos Medical by 63.0% in the third quarter. KBC Group NV now owns 2,833 shares of the company’s stock worth $68,000 after purchasing an additional 1,095 shares during the last quarter. Canada Pension Plan Investment Board purchased a new position in shares of Avanos Medical in the second quarter worth about $70,000. Intech Investment Management LLC acquired a new stake in shares of Avanos Medical during the third quarter worth about $207,000. Finally, Atom Investors LP purchased a new stake in Avanos Medical in the third quarter valued at approximately $210,000. Institutional investors own 95.17% of the company’s stock.

Avanos Medical Company Profile

Avanos Medical, Inc, a medical technology company, offers medical device solutions in North America, Europe, the Middle East, Africa, the Asia Pacific, and Latin America. It offers a portfolio of chronic care products that include digestive health products, such as Mic-Key enteral feeding tubes, Corpak patient feeding solutions, and NeoMed neonatal and pediatric feeding solutions.